dihexa drug | | 1401708-83-5 Dihexa Peptide Therapy DIHEXA – Research Peptide |

Separate-vials Reconstitution Reference Compound Cagrilintide Vial size 5 mg BAC water 2.0 mL Concentration 2.5 mg/mL Weekly draw at 2.4 mg 0.96 mL = 96 units U-100 Compound Cagrilintide Vial size 10 mg BAC water 3.0 mL Concentration 3.33 mg/mL Weekly draw at 2.4 mg 0.72 mL = 72 units U-100 Compound Semaglutide Vial size 5 mg BAC water 2.0 mL Concentration 2.5 mg/mL Weekly draw at 2.4 mg 0.96 mL = 96 units U-100 Compound Semaglutide Vial size 10 mg BAC water 3.0 mL Concentration 3.33 mg/mL Weekly draw at 2.4 mg 0.72 mL = 72 units U-100 Volumes near 1 mL exceed standard U-100 / 0.3 mL syringe capacity

Conclusion and Perspective RA is an autoimmune disease with complex etiology

Accessed October 21, 2024

Power analysis helps researchers avoid inconclusive results from undersized studies